0001140361-17-032607.txt : 20170817 0001140361-17-032607.hdr.sgml : 20170817 20170817163257 ACCESSION NUMBER: 0001140361-17-032607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170815 FILED AS OF DATE: 20170817 DATE AS OF CHANGE: 20170817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hauer Jerome M CENTRAL INDEX KEY: 0001294935 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 171039006 MAIL ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2017-08-15 0 0001367644 Emergent BioSolutions Inc. EBS 0001294935 Hauer Jerome M 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2017-08-15 4 A 0 5153 25.47 A 29421 D Common Stock 2017-08-15 4 S 0 10776 35.8342 D 18645 D Stock Option (Right to Buy) 25.47 2017-08-15 4 M 0 5153 0.00 D 2022-01-21 Common Stock 5153 5152 D Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.05, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. /s/ Eric Burt, Attorney-in-fact 2017-08-17